SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,462 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr | ₹1,463 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,462 Cr |
Mar2023 | ₹1,484 Cr |
Mar2022 | ₹1,487 Cr |
Mar2021 | ₹1,443 Cr |
Mar2020 | ₹1,463 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,462 Cr | -1.46 | |
Mar2023 | ₹1,484 Cr | -0.19 | |
Mar2022 | ₹1,487 Cr | 3.02 | |
Mar2021 | ₹1,443 Cr | -1.38 | |
Mar2020 | ₹1,463 Cr | - |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,709.4 Cr | 0.2% | 2.6% | 24.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,725.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,525.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
CIPLA | ₹123,206.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,519.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,927.5 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 0.2% |
2.6% |
24.6% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses